Main Sector
Biotechnology - Therapeutics and Diagnostics
Subsectors
Anti-infectives
Drug delivery
Nucleic acid drugs
Indications
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Cardiovascular / cardiology
Digestive system / gastroenterology
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Social circumstances / substance related disorders / addiction
Products
In development: 37
On the market: 10
Description
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's product ONPATTRO is a prescription medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). The company's another product AMVUTTRA® (vutrisiran) is an RNAi therapeutic that delivers rapid knockdown of transthyretin (TTR), addressing...
